Drug Type Biological products |
Synonyms RPI MN, pepteron |
Action stimulants, antagonists |
Mechanism IFNγ stimulants(Interferon gamma stimulants), Muscle-type nAChRs antagonists(Muscle-type nicotinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Keratitis, Herpetic | Phase 2 | United States | 24 Feb 2021 | |
Amyotrophic Lateral Sclerosis | Phase 2 | United States | 23 Nov 2015 | |
HIV Infections | Phase 2 | - | - | |
HIV Infections | Phase 2 | South America | - | |
HIV Infections | Phase 2 | South America | - | |
HIV Infections | Phase 2 | China | - | |
HIV Infections | Phase 2 | - | - | |
HIV Infections | Phase 2 | China | - | |
Virus Diseases | Phase 2 | Peru | - | |
Virus Diseases | Phase 2 | Mexico | - |